PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Ontario’s proposed plan to broaden alcohol sales will harm people

2024-04-08
(Press-News.org) The Ontario government’s plans to broaden alcohol sales to privately operated stores in the province could lead to higher consumption rates and related harms, write commentary authors in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.240069.

“These changes will result in a 289% increase in the number of alcohol stores in Ontario (n = 2935 in March 2023, per the Liquor Control Board of Ontario), will likely reduce the price of alcohol, and will represent the biggest shift in decades with respect to how alcohol is sold in Canada,” write Drs. Norman Giesbrecht, Centre for Addiction and Mental Health and University of Toronto, and Daniel Myran, Bruyère Research Institute and The Ottawa Hospital, Ottawa, Ontario.

Extensive evidence indicates that these changes will increase alcohol use and associated harms, such as deaths, hospital visits and admissions, violence, and chronic disease. For example, an analysis of the first 2 years of alcohol sales in Ontario grocery stores found alcohol-related emergency department visits increased by more than 6% in areas with alcohol in grocery stores compared to those without.

The authors call for additional polices to help reduce the risk of negative effects of this policy change.

“We propose instituting policies at the provincial and federal level — including strengthening minimum pricing on alcohol, mandating warning labels on all alcoholic beverages, and increasing access to screening and treatment for alcohol use disorders — to partially mitigate potential harms and costs from these changes.”

Although it is difficult to quantify the harms that may occur, the “public health imperative” posed by these changes warrants action and perhaps a rethink by the Ontario government.

END


ELSE PRESS RELEASES FROM THIS DATE:

Researchers identify an economic solution to Canada's opioid crisis

2024-04-08
Nasal-administered naloxone is more cost-effective and could help reduce the number of opioid-related fatalities compared to the current publicly funded intermuscular version, a new study has found.  Since 2016, Canada's opioid crisis has worsened, with over 40,000 opioid-related deaths, or about 22 deaths per day. Most of these accidental deaths (88 per cent) occur in British Columbia, Alberta and Ontario.  An effective way to help prevent opioid-related deaths is through community pharmacy-based naloxone programs. Currently, ...

Cancer stage compared with mortality as end points in randomized clinical trials of cancer screening

2024-04-08
About The Study: In this systematic review and meta-analysis that included 41 randomized clinical trials of cancer screening, incidence of late-stage cancer may be a suitable alternative end point to cancer-specific mortality for some cancer types, but is not suitable for others. These results have implications for clinical trials of multicancer screening tests.  Authors: Hilary A. Robbins, Ph.D., M.H.S., M.S.P.H., of the International Agency for Research on Cancer in Lyon, France, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2024.5814) Editor’s ...

$2.3 trillion wasted globally in failed digital transformation programs – costly and complex business strategies are ‘not necessary’

2024-04-08
Strategies implemented by firms are too ambitious and wide-ranging, according to a specialist, with their poor design and structure preventing digital transformation success. Firms seeking to harness new digital technologies, such as artificial intelligence, must approach this organizational change in an entirely new way to avoid contributing to the $2.3 trillion wasted on unsuccessful projects globally so far. This is the message of digital transformation expert Brian Harkin, author of Evolving from Digital Transformation to Digital Acceleration Using The Galapagos Framework, which helps business leaders understand how their approach to digital change ...

Frequently need to pee? App-based therapy can help, finds research

2024-04-08
Combining pelvic floor exercises with behavioral therapy could be more effective than current medical treatments at helping men with frequent urges to urinate, new research in men has found. The initial results from the Bladder Emptying Disorder Therapy (BEST) Trial are presented today [Monday 8 April 2024] at the European Association of Urology Congress in Paris. They reveal that an app-based therapy leads to significant improvements in the lower urinary tract symptoms that many millions of men experience – hesitancy, straining, frequent urges to urinate and emptying the bladder effectively. Full results ...

Boreal forest and tundra regions worst hit over next 500 years of climate change, study shows

2024-04-08
The boreal forest, covering much of Canada and Alaska, and the treeless shrublands to the north of the forest region, may be among the worst impacted by climate change over the next 500 years, according to a new study.   The study, led by researchers at the White Rose universities of York and Leeds, as well as Oxford and Montreal, and ETH, Switzerland, ran a widely-used climate model with different atmospheric concentrations of carbon dioxide to assess the impact climate change could have on the ...

Telephone-based guideline-directed medical therapy optimization in Navajo nation

2024-04-07
About The Study: In this randomized clinical trial including 103 American Indian patients, a telephone-based strategy of remote initiation and titration for outpatients with heart failure with reduced ejection fraction led to improved rates of guideline-directed medical therapy at 30 days compared with usual care. This low-cost strategy could be expanded to other rural settings where access to care is limited.  Authors: Lauren A. Eberly, M.D., M.P.H., of the Indian Health Service in Gallup, New Mexico, is the corresponding author. To access the embargoed study: ...

AACR: Novel immunotherapies show promise for patients with kidney cancer and for solid organ transplant recipients with skin cancer

AACR: Novel immunotherapies show promise for patients with kidney cancer and for solid organ transplant recipients with skin cancer
2024-04-07
ABSTRACTS: CT002, CT003 SAN DIEGO ― Researchers from The University of Texas MD Anderson Cancer Center presented encouraging findings today from two clinical trials in a plenary session highlighting advances in novel immunotherapy approaches at the American Association for Cancer Research (AACR) Annual Meeting 2024. The studies describe the use of chimeric antigen receptor (CAR) T cell therapy in patients with advanced kidney cancer and an oncolytic immunotherapy for patients with skin cancer following organ transplants. Information on all MD Anderson AACR Annual Meeting content can be found at MDAnderson.org/AACR. Novel allogenic ...

New Phase 1 data from Memorial Sloan Kettering Cancer Center shows an investigational cancer vaccine may elicit lasting immune response in patients with pancreatic cancer

New Phase 1 data from Memorial Sloan Kettering Cancer Center shows an investigational cancer vaccine may elicit lasting immune response in patients with pancreatic cancer
2024-04-07
New data presented today by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate, autogene cevumeran, continues to show potential to stimulate an immune response that may reduce the risk of the disease returning after surgery. New results from a phase 1 clinical trial show that the cancer vaccine candidate activated immune cells that persisted in the body for up to three years after treatment in certain patients. In addition, a vaccine-induced immune ...

Clinical benefit and regulatory outcomes of cancer drugs receiving accelerated approval

2024-04-07
About The Study: Most cancer drugs granted accelerated approval did not demonstrate benefit in overall survival or quality of life within five years of accelerated approval. Patients should be clearly informed about the cancer drugs that use the accelerated approval pathway and do not end up showing benefits in patient-centered clinical outcomes.  Authors: Aaron S. Kesselheim, M.D., J.D., M.P.H., of Brigham and Women’s Hospital and Harvard Medical School in Boston, is the corresponding author. To access the embargoed ...

Remote care approach improved therapy adherence and uptake in patients with type 2 diabetes

2024-04-07
KEY TAKEAWAYS Researchers at Mass General Brigham tested a remote patient education and navigation program with 200 patients who had type 2 diabetes and elevated cardiovascular/kidney risk. Patients who received education simultaneously with treatment were more likely to begin and adhere to treatment while a period of education prior to therapy initiation was inferior for prescription acceptance and therapy uptake. The study highlights the importance of “striking while the iron is hot” and the potential for remote, team-based care to bridge ...

LAST 30 PRESS RELEASES:

More time spent on social media linked to steroid use intentions among boys and men

New study suggests a “kick it while it’s down” approach to cancer treatment could improve cure rates

Milken Institute, Ann Theodore Foundation launch new grant to support clinical trial for potential sarcoidosis treatment

New strategies boost effectiveness of CAR-NK therapy against cancer

Study: Adolescent cannabis use linked to doubling risk of psychotic and bipolar disorders

Invisible harms: drug-related deaths spike after hurricanes and tropical storms

Adolescent cannabis use and risk of psychotic, bipolar, depressive, and anxiety disorders

Anxiety, depression, and care barriers in adults with intellectual and developmental disabilities

Study: Anxiety, gloom often accompany intellectual deficits

Massage Therapy Foundation awards $300,000 research grant to the University of Denver

Gastrointestinal toxicity linked to targeted cancer therapies in the United States

Countdown to the Bial Award in Biomedicine 2025

Blood marker from dementia research could help track aging across the animal world

Birds change altitude to survive epic journeys across deserts and seas

Here's why you need a backup for the map on your phone

ACS Central Science | Researchers from Insilico Medicine and Lilly publish foundational vision for fully autonomous “Prompt-to-Drug” pharmaceutical R&D

Increasing the number of coronary interventions in patients with acute myocardial infarction does not appear to reduce death rates

Tackling uplift resistance in tall infrastructures sustainably

Novel wireless origami-inspired smart cushioning device for safer logistics

Hidden genetic mismatch, which triples the risk of a life-threatening immune attack after cord blood transplantation

Physical function is a crucial predictor of survival after heart failure

Striking genomic architecture discovered in embryonic reproductive cells before they start developing into sperm and eggs

Screening improves early detection of colorectal cancer

New data on spontaneous coronary artery dissection (SCAD) – a common cause of heart attacks in younger women

How root growth is stimulated by nitrate: Researchers decipher signalling chain

Scientists reveal our best- and worst-case scenarios for a warming Antarctica

Cleaner fish show intelligence typical of mammals

AABNet and partners launch landmark guide on the conservation of African livestock genetic resources and sustainable breeding strategies

Produce hydrogen and oxygen simultaneously from a single atom! Achieve carbon neutrality with an 'All-in-one' single-atom water electrolysis catalyst

Sleep loss linked to higher atrial fibrillation risk in working-age adults

[Press-News.org] Ontario’s proposed plan to broaden alcohol sales will harm people